HEADER HYDROLASE/HYDROLASE INHIBITOR 09-NOV-09 3KM4
TITLE OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN INHIBITORS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RENIN;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: ANGIOTENSINOGENASE;
COMPND 5 EC: 3.4.23.15;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: HUMAN_RENIN, REN;
SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606;
SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 CELLS;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1
KEYWDS RENIN, ASPARTATE PROTEASE, HYPERTENSION, RENIN EXPRESSION, RENIN
KEYWDS 2 INHIBITOR, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES,
KEYWDS 3 DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED,
KEYWDS 4 ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR Z.WU,B.M.MCKEEVER
REVDAT 5 06-NOV-24 3KM4 1 REMARK
REVDAT 4 06-SEP-23 3KM4 1 HETSYN
REVDAT 3 29-JUL-20 3KM4 1 COMPND REMARK HETNAM LINK
REVDAT 3 2 1 SITE ATOM
REVDAT 2 19-JUN-13 3KM4 1 JRNL VERSN
REVDAT 1 12-JAN-10 3KM4 0
JRNL AUTH Z.XU,S.CACATIAN,J.YUAN,R.D.SIMPSON,L.JIA,W.ZHAO,C.M.TICE,
JRNL AUTH 2 P.T.FLAHERTY,J.GUO,A.ISHCHENKO,S.B.SINGH,Z.WU,B.M.MCKEEVER,
JRNL AUTH 3 B.B.SCOTT,Y.BUKHTIYAROV,J.BERBAUM,J.MASON,R.PANEMANGALORE,
JRNL AUTH 4 M.G.CAPPIELLO,R.BENTLEY,C.P.DOE,R.K.HARRISON,G.M.MCGEEHAN,
JRNL AUTH 5 L.W.DILLARD,J.J.BALDWIN,D.A.CLAREMON
JRNL TITL OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN
JRNL TITL 2 INHIBITORS.
JRNL REF BIOORG.MED.CHEM.LETT. V. 20 694 2010
JRNL REFN ISSN 0960-894X
JRNL PMID 19959358
JRNL DOI 10.1016/J.BMCL.2009.11.066
REMARK 2
REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0019
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 82.2
REMARK 3 NUMBER OF REFLECTIONS : 48486
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.203
REMARK 3 R VALUE (WORKING SET) : 0.200
REMARK 3 FREE R VALUE : 0.261
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 2591
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95
REMARK 3 REFLECTION IN BIN (WORKING SET) : 3701
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.06
REMARK 3 BIN R VALUE (WORKING SET) : 0.2760
REMARK 3 BIN FREE R VALUE SET COUNT : 171
REMARK 3 BIN FREE R VALUE : 0.3320
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 5167
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 186
REMARK 3 SOLVENT ATOMS : 462
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.11
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.39000
REMARK 3 B22 (A**2) : 2.07000
REMARK 3 B33 (A**2) : -0.68000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.198
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.187
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.114
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.874
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5489 ; 0.022 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7450 ; 2.119 ; 1.991
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 667 ; 8.015 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;35.828 ;24.144
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 857 ;16.337 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;13.319 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 831 ; 0.145 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4103 ; 0.011 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2568 ; 0.229 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3757 ; 0.321 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 546 ; 0.271 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 51 ; 0.259 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.383 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3307 ; 1.231 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5345 ; 2.030 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2182 ; 3.200 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2105 ; 4.692 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3KM4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-09.
REMARK 100 THE DEPOSITION ID IS D_1000056163.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-MAR-05
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 14-ID-B
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9000
REMARK 200 MONOCHROMATOR : SI (111) DOUBLE-CRYSTAL
REMARK 200 MONOCHROMATOR
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62269
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860
REMARK 200 RESOLUTION RANGE LOW (A) : 81.110
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0
REMARK 200 DATA REDUNDANCY : 4.700
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.06600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.8600
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95
REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3
REMARK 200 DATA REDUNDANCY IN SHELL : 4.60
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.31940
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.690
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: PDB ENTRY 3D91
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.12
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL PH=7.0-8.0, 0.2M
REMARK 280 (NH4)2SO4, 18-26%(W/V) PEG3350, 5MG/ML RENIN, 1MM INHIBITOR,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.91700
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.28400
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.47000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.28400
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.91700
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.47000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2810 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 27140 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER B 166
REMARK 465 GLU B 167
REMARK 465 ASN B 168
REMARK 465 SER B 169
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE1 GLN B 170 O HOH B 466 1.89
REMARK 500 O HOH B 423 O HOH B 570 2.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 TYR A 15 CD1 TYR A 15 CE1 -0.108
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 LEU A 215 CA - CB - CG ANGL. DEV. = 20.7 DEGREES
REMARK 500 ARG B 321 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500 LEU B 338 CA - CB - CG ANGL. DEV. = 18.0 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 5 22.99 -142.46
REMARK 500 ASP A 17 15.45 59.61
REMARK 500 ASN A 75 -66.46 -126.59
REMARK 500 ARG A 82 64.50 -102.72
REMARK 500 THR A 312 146.67 -178.47
REMARK 500 ASN B 5 -10.19 -143.89
REMARK 500 SER B 8 135.16 -174.64
REMARK 500 ASP B 17 13.05 58.49
REMARK 500 ASN B 75 -62.80 -141.27
REMARK 500 ARG B 139 18.04 49.38
REMARK 500 ALA B 299 48.79 -85.02
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 VAL A 225 ASP A 226 -148.28
REMARK 500 THR B 6 THR B 7 148.46
REMARK 500
REMARK 500 REMARK: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3GW5 RELATED DB: PDB
REMARK 900 SAME PROTEIN CO-CRYSTALLIZED WITH A RELATED INHIBITOR
REMARK 900 RELATED ID: 3D91 RELATED DB: PDB
REMARK 900 SAME PROTEIN CO-CRYSTALLIZED WITH INHIBITOR, REMIKIREN
DBREF 3KM4 A 4 340 UNP P00797 RENI_HUMAN 70 406
DBREF 3KM4 B 4 340 UNP P00797 RENI_HUMAN 70 406
SEQRES 1 A 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET
SEQRES 2 A 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO
SEQRES 3 A 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER
SEQRES 4 A 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR
SEQRES 5 A 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP
SEQRES 6 A 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU
SEQRES 7 A 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN
SEQRES 8 A 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET
SEQRES 9 A 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET
SEQRES 10 A 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE
SEQRES 11 A 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN
SEQRES 12 A 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER
SEQRES 13 A 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU
SEQRES 14 A 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS
SEQRES 15 A 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR
SEQRES 16 A 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY
SEQRES 17 A 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU
SEQRES 18 A 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER
SEQRES 19 A 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS
SEQRES 20 A 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO
SEQRES 21 A 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU
SEQRES 22 A 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER
SEQRES 23 A 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA
SEQRES 24 A 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU
SEQRES 25 A 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP
SEQRES 26 A 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG
SEQRES 1 B 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET
SEQRES 2 B 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO
SEQRES 3 B 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER
SEQRES 4 B 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR
SEQRES 5 B 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP
SEQRES 6 B 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU
SEQRES 7 B 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN
SEQRES 8 B 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET
SEQRES 9 B 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET
SEQRES 10 B 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE
SEQRES 11 B 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN
SEQRES 12 B 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER
SEQRES 13 B 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU
SEQRES 14 B 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS
SEQRES 15 B 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR
SEQRES 16 B 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY
SEQRES 17 B 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU
SEQRES 18 B 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER
SEQRES 19 B 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS
SEQRES 20 B 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO
SEQRES 21 B 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU
SEQRES 22 B 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER
SEQRES 23 B 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA
SEQRES 24 B 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU
SEQRES 25 B 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP
SEQRES 26 B 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG
MODRES 3KM4 ASN A 75 ASN GLYCOSYLATION SITE
MODRES 3KM4 ASN B 75 ASN GLYCOSYLATION SITE
HET NAG C 1 14
HET NAG C 2 14
HET 22X A 400 36
HET 22X A 341 36
HET NAG B 600 14
HET 22X B 400 36
HET 22X B 341 36
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
HETNAM 22X (3R)-3-[(1S)-4-(ACETYLAMINO)-1-(3-CHLOROPHENYL)-1-
HETNAM 2 22X HYDROXYBUTYL]-N-{(1S)-2-CYCLOHEXYL-1-[(METHYLAMINO)
HETNAM 3 22X METHYL]ETHYL}PIPERIDINE-1-CARBOXAMIDE
HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-
HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-
HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE
FORMUL 3 NAG 3(C8 H15 N O6)
FORMUL 4 22X 4(C28 H45 CL N4 O3)
FORMUL 9 HOH *462(H2 O)
HELIX 1 1 TYR A 55 HIS A 61 1 7
HELIX 2 2 ASP A 65 SER A 69 5 5
HELIX 3 3 PRO A 115 MET A 120 1 6
HELIX 4 4 PHE A 132 VAL A 140 5 9
HELIX 5 5 PRO A 142 GLN A 150 1 9
HELIX 6 6 ASP A 182 GLN A 184 5 3
HELIX 7 7 SER A 235 GLY A 247 1 13
HELIX 8 8 GLU A 261 LEU A 265 5 5
HELIX 9 9 THR A 280 VAL A 285 1 6
HELIX 10 10 GLY A 316 ARG A 321 1 6
HELIX 11 11 TYR B 55 HIS B 61 1 7
HELIX 12 12 ASP B 65 SER B 69 5 5
HELIX 13 13 PRO B 115 MET B 120 1 6
HELIX 14 14 PHE B 132 VAL B 140 5 9
HELIX 15 15 PRO B 142 GLN B 150 1 9
HELIX 16 16 ASP B 182 GLN B 184 5 3
HELIX 17 17 SER B 235 GLY B 247 1 13
HELIX 18 18 GLU B 261 LEU B 265 5 5
HELIX 19 19 THR B 280 VAL B 285 1 6
HELIX 20 20 GLY B 316 LYS B 322 1 7
SHEET 1 A 9 LYS A 73 TYR A 83 0
SHEET 2 A 9 GLY A 86 VAL A 99 -1 O LEU A 92 N GLY A 76
SHEET 3 A 9 GLN A 19 ILE A 26 -1 N GLY A 25 O THR A 98
SHEET 4 A 9 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19
SHEET 5 A 9 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8
SHEET 6 A 9 VAL A 157 TYR A 162 -1 N SER A 159 O VAL A 177
SHEET 7 A 9 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158
SHEET 8 A 9 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326
SHEET 9 A 9 TYR A 186 ASN A 194 -1 N HIS A 191 O PHE A 336
SHEET 1 B13 LYS A 73 TYR A 83 0
SHEET 2 B13 GLY A 86 VAL A 99 -1 O LEU A 92 N GLY A 76
SHEET 3 B13 ILE A 102 GLU A 113 -1 O GLU A 110 N PHE A 91
SHEET 4 B13 VAL A 44 PRO A 47 1 N VAL A 44 O GLY A 109
SHEET 5 B13 GLY A 126 GLY A 129 -1 O VAL A 127 N TRP A 45
SHEET 6 B13 GLN A 31 ASP A 38 1 N VAL A 36 O VAL A 128
SHEET 7 B13 GLN A 19 ILE A 26 -1 N ILE A 26 O GLN A 31
SHEET 8 B13 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19
SHEET 9 B13 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8
SHEET 10 B13 VAL A 157 TYR A 162 -1 N SER A 159 O VAL A 177
SHEET 11 B13 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158
SHEET 12 B13 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326
SHEET 13 B13 TYR A 186 ASN A 194 -1 N HIS A 191 O PHE A 336
SHEET 1 C 4 SER A 213 LEU A 216 0
SHEET 2 C 4 GLN A 202 VAL A 210 -1 N VAL A 210 O SER A 213
SHEET 3 C 4 ILE A 268 LEU A 272 -1 O HIS A 271 N GLY A 207
SHEET 4 C 4 LYS A 275 LEU A 279 -1 O LEU A 279 N ILE A 268
SHEET 1 D 6 SER A 213 LEU A 216 0
SHEET 2 D 6 GLN A 202 VAL A 210 -1 N VAL A 210 O SER A 213
SHEET 3 D 6 CYS A 221 VAL A 225 -1 O CYS A 221 N MET A 205
SHEET 4 D 6 TRP A 313 LEU A 315 1 O LEU A 315 N LEU A 224
SHEET 5 D 6 ILE A 232 GLY A 234 -1 N SER A 233 O ALA A 314
SHEET 6 D 6 ILE A 300 ALA A 302 1 O HIS A 301 N ILE A 232
SHEET 1 E 3 LYS A 249 LYS A 250 0
SHEET 2 E 3 TYR A 255 LYS A 258 -1 O VAL A 256 N LYS A 249
SHEET 3 E 3 LEU A 295 THR A 297 -1 O CYS A 296 N VAL A 257
SHEET 1 F 9 LYS B 73 TYR B 83 0
SHEET 2 F 9 GLY B 86 VAL B 99 -1 O GLY B 86 N TYR B 83
SHEET 3 F 9 GLN B 19 ILE B 26 -1 N GLY B 25 O THR B 98
SHEET 4 F 9 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19
SHEET 5 F 9 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8
SHEET 6 F 9 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175
SHEET 7 F 9 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158
SHEET 8 F 9 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326
SHEET 9 F 9 TYR B 186 ASN B 194 -1 N HIS B 191 O PHE B 336
SHEET 1 G13 LYS B 73 TYR B 83 0
SHEET 2 G13 GLY B 86 VAL B 99 -1 O GLY B 86 N TYR B 83
SHEET 3 G13 ILE B 102 GLU B 113 -1 O GLN B 106 N ASP B 95
SHEET 4 G13 VAL B 44 PRO B 47 1 N VAL B 46 O VAL B 111
SHEET 5 G13 GLY B 126 GLY B 129 -1 O VAL B 127 N TRP B 45
SHEET 6 G13 GLN B 31 ASP B 38 1 N VAL B 36 O VAL B 128
SHEET 7 G13 GLN B 19 ILE B 26 -1 N GLY B 22 O VAL B 35
SHEET 8 G13 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19
SHEET 9 G13 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8
SHEET 10 G13 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175
SHEET 11 G13 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158
SHEET 12 G13 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326
SHEET 13 G13 TYR B 186 ASN B 194 -1 N HIS B 191 O PHE B 336
SHEET 1 H 3 GLN B 202 MET B 205 0
SHEET 2 H 3 CYS B 221 VAL B 225 -1 O ALA B 223 N ILE B 203
SHEET 3 H 3 TRP B 313 LEU B 315 1 O LEU B 315 N LEU B 224
SHEET 1 I 4 SER B 213 LEU B 216 0
SHEET 2 I 4 VAL B 208 VAL B 210 -1 N VAL B 208 O LEU B 215
SHEET 3 I 4 ILE B 268 LEU B 272 -1 O SER B 269 N SER B 209
SHEET 4 I 4 LYS B 275 LEU B 279 -1 O TYR B 277 N PHE B 270
SHEET 1 J 2 ILE B 232 GLY B 234 0
SHEET 2 J 2 ILE B 300 ALA B 302 1 O HIS B 301 N ILE B 232
SHEET 1 K 3 LYS B 249 LYS B 250 0
SHEET 2 K 3 TYR B 255 LYS B 258 -1 O VAL B 256 N LYS B 249
SHEET 3 K 3 LEU B 295 THR B 297 -1 O CYS B 296 N VAL B 257
SSBOND 1 CYS A 51 CYS A 58 1555 1555 2.03
SSBOND 2 CYS A 217 CYS A 221 1555 1555 2.09
SSBOND 3 CYS A 259 CYS A 296 1555 1555 2.02
SSBOND 4 CYS B 51 CYS B 58 1555 1555 2.02
SSBOND 5 CYS B 217 CYS B 221 1555 1555 2.08
SSBOND 6 CYS B 259 CYS B 296 1555 1555 2.10
LINK ND2 ASN A 75 C1 NAG C 1 1555 1555 1.43
LINK ND2 ASN B 75 C1 NAG B 600 1555 1555 1.62
LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45
CISPEP 1 THR A 28 PRO A 29 0 -1.51
CISPEP 2 LEU A 117 PRO A 118 0 11.27
CISPEP 3 PRO A 307 PRO A 308 0 5.71
CISPEP 4 GLY A 310 PRO A 311 0 3.05
CISPEP 5 THR B 28 PRO B 29 0 -10.30
CISPEP 6 LEU B 117 PRO B 118 0 15.54
CISPEP 7 PRO B 307 PRO B 308 0 -1.45
CISPEP 8 GLY B 310 PRO B 311 0 -5.39
CRYST1 53.834 96.940 148.568 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018576 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010316 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006731 0.00000